Back to search

Netherlands· NL-19a1912548f5

Latuda 74 mg, filmomhulde tabletten

A lurasidone product containing lurasidonhydrochloride, registered in Netherlands by Aziende Chimiche Riunite Angelini Francesco S.p.A.. The same ATC class is registered in 16 of our 19 countries.

ATC N05AE05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedLatuda 74 mg, filmomhulde tablettenATCN05AE05REGISTER NO.NL-19a1912548f5PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Lurasidone is registered in 16 of 19 countries.

Countries holding a registration under ATC N05AE05 (lurasidone), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose

Lurasidone · ATC N05AE05

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lurasidone costs, country by country.

Normalised to the WHO defined daily dose (60 mg), the median price runs from $2.63 in Italy to $6.45 in Switzerland — a ×2.4 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Lurasidone · price per daily dose (60 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$6.45
  • IT Italy$2.63
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
LURASIDONHYDROCHLORIDE
Manufacturer
Aziende Chimiche Riunite Angelini Francesco S.p.A.
Country
Netherlands (NL)
ATC code
N05AE05
ATC class
Lurasidone
Defined daily dose
60 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/14/913

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

242 interactions on record for lurasidone.

Graded by severity as the source publishes them — 32 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lurasidone · interactions on record

242 records

  • 32 severe
  • 205 moderate

Most severe, free to view

  • MetoclopramideA03FA01severe
  • AprepitantA04AD12severe
  • KetoconazoleH02CA03severe
  • ErythromycinJ01FA01severe

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lurasidone in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lurasidone products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Austria · Lurasidon G.L., Lurasidon Genericon
  • Bulgaria · Lurasidone Accord, Луразидон Тева
  • Czechia · Isaq, Lurasidon G.L. Pharma
  • Germany · Lurasidon Elpen
  • Denmark · Elgera, Lurasidone Accord
  • Spain · Lurasidona Cinfa, Lurasidona Tecnigen
  • Finland · Lurasidone Accord
  • United Kingdom (Northern Ireland) · Lurasidone Accord Healthcare, Lurasidone Amarox
  • Greece · Elgera, Latomno
  • Croatia · Lurasidon Teva
  • Iceland · Latuda
  • Italy · Lurasidone Accord, Lurasidone Doc
  • Liechtenstein · Latuda
  • Norway · Latuda, Lurasidone Accord
  • Poland · Alurazen, Asil
  • Portugal · Latomno, Lurasidona Farmoz
  • Sweden · Lurasidon G.L. Pharma, Lurasidone Accord
  • Slovenia · Lurasidon Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/875544f5-3d30-4b06-b02b-b24d80f6a68d
GET /v1/drugs/875544f5-3d30-4b06-b02b-b24d80f6a68d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/latuda-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Lurasidone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp112908",
  "excipients": [
    "CARNAUBAWAS (E 903)",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "INDIGOKARMIJN (E 132)",
    "MACROGOL 8000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MANNITOL (D-) (E 421)",
    "TITAANDIOXIDE (E 171)",
    "ZETMEEL, GEPREGELATINEERD"
  ],
  "substances": [
    "LURASIDONHYDROCHLORIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2014/03/21",
  "procedure_number": "EMEA/H/C/002713",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/14/913",
  "additional_monitoring": "N"
}

See everything about lurasidone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.